Gupta; Jang Bahadur

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gupta; Jang Bahadur.The latest application filed is for "substituted azabicyclo hexane derivatives as muscarinic receptor antagonists".

Company Profile

0.13.17

Gupta; Jang Bahadur - Dusseldorf DE
Gupta; Jang Bahadur - Hyogo JP
Gupta; Jang Bahadur - Haryana IN
Gupta; Jang Bahadur - Kobe JP
Gupta; Jang Bahadur - Gurgaon IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists Grant 7,592,359 - Mehta , et al. September 22, 2	2009-09-22
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists Grant 7,517,905 - Mehta , et al. April 14, 2	2009-04-14
Flavaxate derivatives as muscarinic receptor antagonists Grant 7,501,443 - Mehta , et al. March 10, 2	2009-03-10
3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists Grant 7,488,748 - Mehta , et al. February 10, 2	2009-02-10
1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists Grant 7,465,751 - Mehta , et al. December 16, 2	2008-12-16
3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists Grant 7,410,993 - Mehta , et al. August 12, 2	2008-08-12
3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists Grant 7,399,779 - Mehta , et al. July 15, 2	2008-07-15
Substituted Azabicyclo Hexane Derivatives as Muscarinic Receptor Antagonists App 20070287732 - Mehta; Anita ; et al.	2007-12-13
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists Grant 7,288,562 - Mehta , et al. October 30, 2	2007-10-30
3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists Grant 7,265,147 - Mehta , et al. September 4, 2	2007-09-04
3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists Grant 7,232,835 - Mehta , et al. June 19, 2	2007-06-19
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists App 20070010568 - Mehta; Anita ; et al.	2007-01-11
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists App 20060281805 - Mehta; Anita ; et al.	2006-12-14
3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists App 20060247225 - Mehta; Anita ; et al.	2006-11-02
Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers App 20060247249 - Salman; Mohammad ; et al.	2006-11-02
Derivatives of azasugars as anticancer agents App 20060241114 - Arora; Jasbir Singh ; et al.	2006-10-26
3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists App 20060217432 - Mehta; Anita ; et al.	2006-09-28
1-Substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists App 20060194862 - Mehta; Anita ; et al.	2006-08-31
3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor App 20060142371 - Mehta; Anita ; et al.	2006-06-29
Flavaxate derivatives as muscarinic receptor antagonists App 20060128781 - Mehta; Anita ; et al.	2006-06-15
3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists App 20060122253 - Mehta; Anita ; et al.	2006-06-08
Derivatives of monosaccharides as cell adhesion inhibitors Grant 7,037,899 - Arora , et al. May 2, 2	2006-05-02
Derivatives of monosaccharides as cell adhesion inhibitors Grant 7,005,422 - Arora , et al. February 28, 2	2006-02-28
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists App 20060004083 - Mehta; Anita ; et al.	2006-01-05
Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers App 20050228180 - Salman, Mohammad ; et al.	2005-10-13
1,4-Disubstituted piperazine derivatives useful as uro-selective .alpha.1-adrenoceptor blockers Grant 6,914,064 - Anand , et al. July 5, 2	2005-07-05
Derivatives of monosaccharides as cell adhesion inhibitors App 20040023900 - Arora, Sudershan K. ; et al.	2004-02-05
Derivatives of monosaccharides as cell adhesion inhibitors App 20040018995 - Arora, Sudershan K. ; et al.	2004-01-29
Derivatives of monosaccharides as cell adhesion inhibitors App 20040019191 - Arora, Sudershan K. ; et al.	2004-01-29
1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers App 20020156085 - Anand, Nitya ; et al.	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.